Clinical updates, including trial initiations, enrollment status and data readouts and publications: ABM, ACM, Addex, Biohaven, Cantargia, Eledon, Escocap, Genmab, Iliad, Insmed, Invlos, Mindbio, Nuvalent, Oncopeptides, Oncorena, Plus, Rallybio, Sareum, Seagen, Stoke, Tonix, Tris.